Supreme Court grants bail to 17 Gujarat mass massacre CONVICTS, asks admin to find them work

Bengaluru, Jun 8: Karnataka recorded 308 new COVID-19 cases in the past 24 hours, with the majority of patients being domestic returnees, raising the state's tally to 5,760 an official said, here on Monday. "Over 308 new cases were reported from Sunday 5 pm to Monday 5 pm," said the health official.

Like everyday Maharashtra returnees accounted for 96 per cent (267 cases) of the 277 new cases. Majority infections in Karnataka nowadays are returnees, mostly from the state's northern neighbour.

A few returnees also came from Tamil Nadu, Telangana and Andhra Pradesh. There was one international returnee, a 23-year-old man from Dakshina Kannada, who came from the UAE. Only 24 new infections were contacts of earlier cases.

On Monday, cases spiked in Kalaburagi, Yadgir, Bidar, Udupi, Bengaluru Urban, Ballari and Gadag.

Among the new cases, Kalaburagi contributed (99), followed by Yadgir (66), Bidar (48), Udupi (45), Bengaluru Urban (18), Ballari (8), Gadag (6), Shivamogga and Dharwad (4 each), Hassan and Dakshina Kannada (3 each), Bagalkote (2) and Koppal and Ramnagar (1 each). Four patients are suffering from Influenza-Like Illness (ILI).

Meanwhile, record 387 patients got discharged in the past 24 hours. On Monday, three persons - A 67-year-old man, a 48-year-old woman and another 65-year-old woman, all from Bengaluru Urban, succumbed to coronavirus.

Of all the cases, 3,175 are active, 2,519 discharged, 64 dead and 14 in the ICU.

In the past 24 hours, Karnataka tested 8,779 people. Of this, 8,231 reports returned negative. A number of tests were lower than other days. In total, 3.93 lac samples have been tested so far, of which 3.8 lac have returned negative.

Currently, Udupi is leading the state's COVID-19 burden with 628 active cases, followed by Kalaburagi (539), Yadgir (488), Raichur (276) and Bengaluru Urban (176) among others.

Bengaluru Urban has accounted for 18 deaths, followed by Kalaburagi (7), Bidar, Vijayapura, Davangere and Dakshina Kannada (6 each) and Chikkaballapur (3 each), among others.

Newsroom, Feb 2: American business magnate Bill Gates has congratulated her daughter Jennifer Gates after she announced her engagement to her Muslim boyfriend Nayel Nassar.

“I am completely thrilled! Congratulations, @jenniferkgates and @nayelnassar”, commented the Microsoft boss to her daughter’s surprise Instagram story.

The proposal took place on a ski getaway. "Nayel Nassar, you are one of a kind. Absolutely swept me off my feet this past weekend, surprising me in the most meaningful location over one of our many shared passions," she wrote on Instagram. The pair does have one very significant shared passion - horses.

Nassar, 29, is a showjumper. Gates, 23, has famously grown up an equestrian, and has even competed against Steve Jobs' daughter.

In October, Nassar helped Egypt qualify for Tokyo 2020 - Egypt's first Olympic equestrian qualification in 60 years. He has been jumping since he was 10 years old and has the accolades to show for it - he has taken first place in a number of notable competitions, including the Longines FEI Jumping World Cup.

Nassar was born in Chicago to Egyptian parents and spent many of his formative years in Kuwait, where his well-to-do parents run an architecture and design firm, according to People. He is fluent in English, Arabic, and French.

He moved back to the US in 2009 and graduated from Stanford with an economics degree in 2013 - later, he supported Gates at her own Stanford graduation in 2018.

The couple received well wishes from many notable personalities on each of their Instagram posts, including comments from Bill and Melinda Gates, Georgina Bloomberg, and Eve Jobs.

 

 

 

 

View this post on Instagram

 

 

 

 

 

 

 

 

 

Happy birthday @nayelnassar, can’t begin to put into words how extraordinary you are. The most compassionate, intelligent, hilarious, supportive, warm, humble human being. Wishing you all the joy in the world today and all the years to come

A post shared by Jennifer Gates (@jenniferkgates) on Jan 21, 2020 at 8:44am PST

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.